Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced today the publication of a new peer-reviewed paper in Expert Opinion on Investigational Drugs ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE